Deutsche Bank
ACET icon

Deutsche Bank’s Adicet Bio ACET Stock Holding History

Deutsche Bank’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-119
Closed -$2.3K – 3601
2024
Q2 		$2.3K Sell
119
-2,673
-96% -$71.6K ﹤0.01% 3519
2024
Q1 		$105K Sell
2,792
-65
-2% -$2.69K ﹤0.01% 3146
2023
Q4 		$86.4K Buy
2,857
+2,506
+714% +$54.6K ﹤0.01% 3285
2023
Q3 		$7.7K Sell
351
-63,468
-99% -$2.24M ﹤0.01% 3578
2023
Q2 		$2.48M Buy
63,819
+61,856
+3,151% +$5.46M ﹤0.01% 1522
2023
Q1 		$181K Sell
1,963
-40,736
-95% -$5.11M ﹤0.01% 3053
2022
Q4 		$6.11M Buy
42,699
+450
+1% +$112K ﹤0.01% 1142
2022
Q3 		$9.61M Sell
42,249
-118
-0.3% -$30K 0.01% 969
2022
Q2 		$9.9M Buy
42,367
+4
+0% +$878 0.01% 997
2022
Q1 		$13.5M Buy
42,363
+40,588
+2,287% +$9.34M 0.01% 970
2021
Q4 		$497K Buy
1,775
+41
+2% +$7.04K ﹤0.01% 2856
2021
Q3 		$217K Buy
1,734
+958
+123% +$119K ﹤0.01% 3525
2021
Q2 		$128K Buy
+776
New +$158K ﹤0.01% 4034
2020
Q3 		– Sell
-12
Closed -$3K – 4314
2020
Q2 		$3K Sell
12
-380
-97% -$74.7K ﹤0.01% 4172
2020
Q1 		$45K Sell
392
-3
-0.8% -$445 ﹤0.01% 3591
2019
Q4 		$65K Buy
395
+360
+1,029% +$182K ﹤0.01% 3820
2019
Q3 		$34K Sell
35
-3
-8% -$3.35K ﹤0.01% 4109
2019
Q2 		$42K Sell
38
-30
-44% -$27.2K ﹤0.01% 4575
2019
Q1 		$51K Buy
68
+2
+3% +$1.82K ﹤0.01% 4548
2018
Q4 		$63K Sell
66
-91
-58% -$120K ﹤0.01% 4383
2018
Q3 		$267K Buy
157
+36
+30% +$47K ﹤0.01% 4100
2018
Q2 		$125K Buy
121
+46
+61% +$49.5K ﹤0.01% 4460
2018
Q1 		$80K Buy
+75
New +$138K ﹤0.01% 4590

Other funds holding ACET

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Deutsche Bank's ACET Position: Q3 2024 in Review

Deutsche Bank sold out of Adicet Bio (ACET) in Q3 2024, closing a stake of 119 shares — an estimated $2.3K sold.

Deutsche Bank first reported a position in ACET in Q1 2018 and held it in 23 quarters. The position peaked at $13.5M in Q1 2022. 64 funds tracked by Wall St. Rank hold ACET as of Q3 2024.

  • Deutsche Bank reported no remaining Adicet Bio position as of Q3 2024 after selling out during the quarter.
  • Deutsche Bank sold 119 Adicet Bio shares in Q3 2024, an estimated $2.3K.
  • Deutsche Bank first reported a position in Adicet Bio in Q1 2018 and held it in 23 quarters.
  • Deutsche Bank's Adicet Bio position peaked at $13.5M in Q1 2022.
  • 64 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2024.

Based on Deutsche Bank's 13F filing for Q3 2024, filed 13 Nov 2024.